Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill
- 31 January 2023
- journal article
- research article
- Published by Elsevier BV in Contraception
- Vol. 121, 109961
- https://doi.org/10.1016/j.contraception.2023.109961
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019The Lancet. Global Health, 2020
- A study of Centchroman users with special reference to its contraceptive benefitInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2019
- Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pillBMJ Open, 2019
- The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisionsInternational Journal of Gynecology & Obstetrics, 2018
- A PROSPECTIVE STUDY OF CENTCHROMAN USERS WITH SPECIAL REFERENCE TO ITS CONTRACEPTIVE BENEFITJournal of Evidence Based Medicine and Healthcare, 2016
- Clinical pharmacokinetics and interaction of centchroman — A mini reviewContraception, 2010
- Oral contraceptive discontinuation: A prospective evaluation of frequency and reasonsAmerican Journal of Obstetrics and Gynecology, 1998
- Contraceptive Discontinuation in Six Developing Countries: A Cause-Specific AnalysisInternational Family Planning Perspectives, 1995
- Early Discontinuation of Contraceptive Use In Niger and The GambiaInternational Family Planning Perspectives, 1992